“TB in Rural India: Cultural Beliefs and Their Impact on Treatment Adherence”
A Comprehensive Study on Tuberculosis: Causes, Symptoms, Diagnosis, Treatment, and Prevention
Abstract
Tuberculosis (TB) is one of the oldest and most persistent infectious diseases in human history. It is caused by the bacterium Mycobacterium tuberculosis, which primarily affects the lungs but can also spread to other organs. Despite being curable and preventable, TB remains a major global health challenge. Nearly one-fourth of the world’s population is infected with TB bacteria, though most individuals do not develop active disease. TB spreads through the air when a person with active pulmonary TB coughs, sneezes, or speaks. Diagnosis requires specific laboratory and imaging tests, and treatment involves long-term antibiotic therapy. The World Health Organization (WHO) has set ambitious goals through the End TB Strategy to reduce deaths and new cases globally. This thesis discusses the causes, symptoms, diagnosis, treatment, prevention, and global impact of tuberculosis in detail.
Introduction
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. It primarily affects the lungs (pulmonary TB) but can also involve other parts of the body such as the kidneys, spine, brain, and lymph nodes (extrapulmonary TB). The disease has been known for centuries and has caused immense human suffering and death. TB remains a major global concern, especially in developing countries where poverty, malnutrition, and inadequate healthcare facilities contribute to its spread.
TB is transmitted from person to person through airborne droplets released when an infected person coughs or sneezes. Most infections remain latent, but about 10% of infected people develop active disease during their lifetime. Factors like HIV infection, diabetes, smoking, and weak immunity increase the risk of developing active TB.
The disease not only affects health but also has social and economic impacts on families and nations. Therefore, effective prevention, early diagnosis, and complete treatment are essential for TB control.
Historical Background
Evidence of tuberculosis has been found in ancient Egyptian mummies, showing that the disease existed more than 4000 years ago. The term "tuberculosis" was introduced in the early 19th century. In 1882, Dr. Robert Koch discovered the causative agent Mycobacterium tuberculosis, which was a major milestone in medical science.
In the early 20th century, the development of the BCG vaccine (Bacillus Calmette–Guérin) provided a preventive measure against TB. Later, with the discovery of antibiotics like streptomycin and isoniazid, effective treatment became possible. Despite these advancements, TB continues to affect millions of people worldwide, especially in low-income countries.
Etiology (Causative Agent)
The bacterium responsible for tuberculosis is Mycobacterium tuberculosis, a rod-shaped, acid-fast bacillus. It is non-motile and aerobic, meaning it needs oxygen to survive, which is why it primarily affects the lungs.
The cell wall of this bacterium contains a high amount of lipids, making it resistant to drying, disinfectants, and antibiotics. It grows slowly, taking 2–6 weeks to form colonies in culture.
Other bacteria that can cause similar infections include Mycobacterium bovis (found in cattle) and Mycobacterium africanum. However, M. tuberculosis is the most common cause in humans.
Pathogenesis
When a person inhales droplets containing Mycobacterium tuberculosis, the bacteria reach the alveoli of the lungs. Here, they are engulfed by macrophages (immune cells), but instead of being destroyed, the bacteria survive and multiply inside them.
In most healthy individuals, the immune system controls the infection by forming granulomas (small nodules) that trap the bacteria. This is known as latent TB infection.
If the immune system weakens later, the bacteria can become active again, leading to active TB disease. Active TB damages tissues, especially in the lungs, and makes the person infectious to others.
Epidemiology
According to the World Health Organization (WHO), around 10 million new TB cases are reported each year, and over 1.3 million deaths occur annually. About 25% of the world’s population is estimated to have latent TB infection.
India, China, Indonesia, the Philippines, and Pakistan are among the countries with the highest TB burden.
The disease affects both men and women, but men are more commonly affected. People with HIV infection are at 13 times higher risk, and those with diabetes or who smoke also have a higher chance of developing TB.
Symptoms and Diagnosis
Common Symptoms:
-
Persistent cough for more than 2–3 weeks
-
Coughing up sputum or blood
-
Fever, especially in the evening
-
Night sweats
-
Loss of appetite and weight loss
-
Fatigue and weakness
Diagnosis:
-
Sputum Test: The patient’s sputum is examined under a microscope to detect acid-fast bacilli (AFB).
-
Chest X-ray: Shows lung damage or cavities typical of TB infection.
-
Mantoux (Tuberculin) Skin Test: A small injection is given under the skin to check immune response to TB bacteria.
-
GeneXpert Test: Detects TB bacteria and drug resistance rapidly.
-
Blood Tests (IGRA): Used to detect latent TB infection.
Treatment
TB is completely curable if treated properly. The main treatment involves a combination of antibiotics taken for at least 6 months.
The standard regimen includes:
-
Isoniazid (H)
-
Rifampicin (R)
-
Ethambutol (E)
-
Pyrazinamide (Z)
This combination is known as the HRZE regimen.
Patients must complete the full course of treatment even if they feel better, otherwise the bacteria may survive and become resistant.
For drug-resistant TB (DR-TB), second-line drugs like levofloxacin, bedaquiline, and linezolid are used, but treatment is longer and more complex.
Prevention and Control
TB prevention requires a multi-level approach:
-
BCG Vaccine: Provides protection against severe forms of TB in children.
-
Early Diagnosis: Detecting and treating TB patients quickly helps stop transmission.
-
Public Awareness: Educating people about TB symptoms, transmission, and treatment.
-
Infection Control: TB patients should wear masks, cover their mouth while coughing, and ensure proper ventilation.
-
WHO’s End TB Strategy: Aims to reduce TB deaths by 90% and new cases by 80% by 2030.
Global and Economic Impact
TB remains one of the top 10 causes of death worldwide. It causes significant social and economic damage.
Many TB patients are unable to work during treatment, leading to loss of income and financial strain.
The cost of long-term medicines, travel for treatment, and nutritional needs can push families into poverty.
Therefore, TB is not just a medical issue but also a socio-economic challenge.
Conclusion
Tuberculosis continues to be one of the deadliest infectious diseases in the world, but it is curable and preventable.
The key lies in early detection, complete treatment, vaccination, and public awareness.
To achieve the WHO’s End TB goal, global cooperation, strong healthcare systems, and patient support are essential.
With continued research and commitment, a TB-free world is possible.
References
-
World Health Organization. Global Tuberculosis Report, 2024.
-
Centers for Disease Control and Prevention (CDC), Tuberculosis (TB) Facts, 2023.
-
Koch, R. (1882). The Etiology of Tuberculosis.
-
Sharma, P.V. (1981). History of Medicine in India.
-
Indian Ministry of Health and Family Welfare. National TB Elimination Programme (NTEP), 2024.
0 टिप्पणियाँ